Innovation Pharmaceuticals Inc (IPIX)

[scottsmith]

PP walked back his harsh assessment after admitting he neglected to review the source material. So I’m not quite ready to use his post to finally conclude B-OM is the superior treatment. Why didn’t you look at PP’s last post on the subject. Me personally, I prefer to review both sides of an argument objectively and examine all the evidence. Some don’t share my zest for the truth unfortunately.

William: I agree B still looks quite strong. But I’d be very surprised if ipix scored a deal with sizable upfront cash. The results and/or sample sizes don’t yet justify it. However, even a deal(s) for 10mm - 20mm upfront cash would be a big deal.